Abiopharma

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

New Form 4 - Shattuck Labs, Inc. Filed: 2025-07-16 AccNo: 0000950170-25-096273 Size: 5 KB

New Form 4 - Envista Holdings Corp Filed: 2025-07-16 AccNo: 0001628280-25-035071 Size: 4 KB

New Form 3 - Envista Holdings Corp Filed: 2025-07-16 AccNo: 0001628280-25-035067 Size: 9 KB

New Form 8-K - Ainos, Inc. Filed: 2025-07-16 AccNo: 0001493152-25-011263 Size: 279 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Indaptus Therapeutics, Inc. Filed: 2025-07-16 AccNo: 0001641172-25-019893 Size: 198 KB Item 8.01: Other Events

New Form 8-K - BriaCell Therapeutics Corp. Filed: 2025-07-16 AccNo: 0001641172-25-019892 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

New Form DEFA14A - Vincerx Pharma, Inc. Filed: 2025-07-16 AccNo: 0001193125-25-159868 Size: 19 KB

New Form 4 - Shattuck Labs, Inc. Filed: 2025-07-16 AccNo: 0000950170-25-096266 Size: 5 KB

New Form 8-K - Envista Holdings Corp Filed: 2025-07-16 AccNo: 0001757073-25-000036 Size: 199 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form DEF 14A - Genprex, Inc. Filed: 2025-07-16 AccNo: 0001437749-25-022834 Size: 3 MB

Notification from BriaCell Therapeutics Corp.

New Form 8-K - Sarepta Therapeutics, Inc. Filed: 2025-07-16 AccNo: 0000950170-25-096257 Size: 284 KB Item 2.02: Results of Operations and Financial Condition Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain …

New Form 4 - Apellis Pharmaceuticals, Inc. Filed: 2025-07-16 AccNo: 0001127602-25-019265 Size: 18 KB